Latest / The Diagnostics & Lab Testing Business Brief
The Diagnostics & Lab Testing Business Brief — Saturday, October 31, 2026
The Diagnostics & Lab Testing Business Brief — Saturday, October 31, 2026
The business behind the tests. Today's developments shaping the diagnostics industry.
Labcorp and Quest press Congress on the RESULTS Act as PAMA payment cuts loom: reported Oct 30, 2026 — both CEOs used their third-quarter earnings calls to push for passage before year-end; CMS's preliminary clinical laboratory fee schedule would cut payments by 15% on 775 tests in 2027, with further reductions in 2028 and 2029; Labcorp quantified a $125 million hit in 2027 and Quest roughly 1% of 2026 revenue; the RESULTS Act would…
The skinny
The skinny isn't ready yet — notes appear once the transcript is processed.